Dermorphin 10 mg
Educational recon guide for a 10 mg Dermorphin research vial with microgram-scale unit mapping only. Extremely potent μ-opioid peptide — research/forensic context, not a recovery or wellness product.
Vial
10 mg
Your BAC water
5 mL
Concentration
2.00 mg/mL
Per unit
~20.0 mcg
Frequency
Study-design dependent (historical work used controlled infusions / specialized routes)
Route
Research literature: IV / specialized routes; catalog vials are not a consumer protocol
Live reconstitution calculator
Defaults match this guide (10 mg + 5 mL BAC). Change water or dose and the unit tables below update automatically.
Step 1
Reconstitution
Peptide amount in the vial and how much bacteriostatic water you add.
Step 2
Your dose
This guide uses microgram-scale research doses — quick picks are in mcg (100 mcg = 0.1 mg).
Quick select (mcg) — switch units or type any value
Suggested: 30-unit barrel (smallest that fits this draw).
Your draw
Results
Total draw
0.5 units
Volume
0.005 mL
Doses per vial
1000
Syringes needed
1
Barrel
30-unit
Fits one syringe?
Yes
30-unit · 0.3 mL
Filled to 0.5 u
Fill one 30-unit U-100 syringe to about 0.5 units (0.005 mL).
Research cycle phases
Units and volumes recompute from your Step 1 concentration (5 mL BAC → 2.00 mg/mL · 20.0 mcg/unit). Doses below are once daily during the course — not weekly.
Standard course
Dermorphin is far more potent than morphine at μ-opioid receptors. Published human experimental work used carefully controlled microgram-scale exposures (e.g. IV mcg/kg/min infusion designs; microgram-level specialized routes). There is no safe “wellness” milligram daily schedule. Tables below are recon/unit illustrations only.
| Phase | Daily dose | Units | Volume |
|---|---|---|---|
| Example · 10 mcg | 10 mcg0.01 mg | 0.5 u | 0.01 mL≈0.5 units @ 5 mL recon — microgram educational example only |
| Example · 25 mcg | 25 mcg0.025 mg | 1.3 u | 0.01 mL≈1.25 units @ 5 mL recon |
| Example · 50 mcg | 50 mcg0.05 mg | 2.5 u | 0.03 mL≈2.5 units @ 5 mL recon — still microgram-scale; not an endorsement |
Alternate / higher courses
Shorter or higher daily courses discussed in research communities — not a clinical recommendation
| Phase | Daily dose | Units | Volume |
|---|---|---|---|
| Example · 100 mcg | 100 mcg0.1 mg | 5 u | 0.05 mL≈5 units @ 5 mL recon — upper educational microgram illustration only |
Supplies planner
Using the guide’s phase ladder (10 mcg → 25 mcg → 50 mcg per injection (phase ladder)) over a 3-day course. Set a dose in Step 2 to plan supplies at your own amount.
Your recon
5 mL · 2.00 mg/mL
Dose in plan
Phase ladder
Syringe size
100-unit
Horizon
3-day course
Dermorphin 10 mg vials
1 vial
~85 mcg mg total peptide over this 3-day course at 10 mcg → 25 mcg → 50 mcg per injection (phase ladder). Each vial holds 10 mg.
Bacteriostatic water
2 × 3 mL or 1 × 10 mL
5 mL BAC per vial × 1 vial = 5.0 mL total. Buy as 2× 3 mL bottles or 1× 10 mL bottle (whichever you stock).
U-100 insulin syringes (100-unit)
3+ syringes
About one 100-unit syringe per injection for this schedule. Keep a few spares.
Alcohol swabs & sharps
~8 swabs · 1 sharps container
Wipe vial stopper and injection site each time. Dispose needles in a proper sharps container.
Reconstitution steps
- Allow the lyophilized 10 mg Dermorphin vial and bacteriostatic water to reach room temperature.
- Draw 5.0 mL bacteriostatic water (default) so microgram amounts map more readably on a U-100 syringe.
- Inject BAC slowly down the inner wall — do not blast the cake.
- Gently swirl until clear. Do not shake hard.
- Label clearly with recon date, concentration, and “OPIOID RESEARCH — mcg scale”.
- Refrigerate at 2–8 °C (35–46 °F). Controlled handling only.
Storage
Lyophilized
Keep dry powder cold and dark when possible (−20 °C / −4 °F preferred for long-term research stock).
Reconstituted
Refrigerate at 2–8 °C (35–46 °F). Avoid freeze–thaw of the working solution. Prefer finishing within ~28 days.
- ·Write recon date and BAC volume on the label.
- ·Protect from light during storage.
- ·Discard if cloudy, particulates, or odd odor appear after reconstitution.
- ·Treat as a controlled high-risk research material — secure storage away from casual access.
Protocol notes
- ·Dermorphin is an amphibian μ-opioid heptapeptide (includes a D-amino acid) with potency far above morphine in classic models.
- ·This page exists so catalog math is explicit at MICROGRAM scale — it is not a pain, sleep, or recovery protocol.
- ·Respiratory depression, dependence, and overdose risk are core opioid-class hazards.
- ·Concurrent CNS depressants (alcohol, benzos, other opioids) dramatically increase danger in any opioid context.
- ·Research use only. Not medical advice.
Research context & considerations
Dermorphin was isolated from Phyllomedusa frog skin secretions and is a selective μ-opioid agonist of exceptional potency. It appears in receptor pharmacology, analgesia models, and forensic discussions. Research powders are not approved analgesics and carry serious abuse and legal risk.
- ·Respiratory depression and fatal overdose risk — same class of hazard as potent opioids.
- ·Dependence and withdrawal potential.
- ·Not a lifestyle, recovery, or “biohacking” peptide.
- ·Legal status may be restricted; verify jurisdiction.
- ·Pregnancy, respiratory disease, and any unsupervised human use are absolute avoid contexts for educational framing.
Catalog match
Dermorphin
10mg x 10 vials · from $40